tiprankstipranks
Lumos Pharma (LUMO)
NASDAQ:LUMO
US Market

Lumos Pharma (LUMO) Technical Analysis

332 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
2Neutral
14Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Lumos Pharma’s (LUMO) Moving Averages Convergence Divergence (MACD) indicator is -0.25, suggesting Lumos Pharma is a Buy.
Lumos Pharma’s (LUMO) 20-Day exponential moving average is 1.87, while Lumos Pharma’s (LUMO) share price is $1.46, making it a Sell.
Lumos Pharma’s (LUMO) 50-Day exponential moving average is 2.19, while Lumos Pharma’s (LUMO) share price is $1.46, making it a Sell.

Lumos Pharma (LUMO) Pivot Points

Jul 22, 2024, 06:45 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.22
1.31
1.38
1.47
1.54
1.63
1.70
Fibonacci
1.31
1.37
1.41
1.47
1.53
1.57
1.63
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Lumos Pharma (LUMO) Moving Averages

Jul 22, 2024, 06:45 PM
Period
Simple
Exponential
MA5
1.49Sell
1.52Sell
MA10
1.66Sell
1.66Sell
MA20
1.96Sell
1.87Sell
MA50
2.27Sell
2.19Sell
MA100
2.55Sell
2.45Sell
MA200
2.90Sell
2.76Sell
Lumos Pharma’s (LUMO) 10-Day exponential moving average is 1.66, while Lumos Pharma’s (LUMO) share price is $1.46, making it a Sell.
Lumos Pharma’s (LUMO) 100-Day exponential moving average is 2.45, while Lumos Pharma’s (LUMO) share price is $1.46, making it a Sell.
Lumos Pharma’s (LUMO) stock price is $1.46 and Lumos Pharma’s (LUMO) 50-day simple moving average is 2.27, creating a Sell signal.
Lumos Pharma’s (LUMO) stock price is $1.46 and Lumos Pharma’s (LUMO) 100-day simple moving average is 2.55, creating a Sell signal.
Lumos Pharma’s (LUMO) stock price is $1.46 and Lumos Pharma’s (LUMO) 200-day simple moving average is 2.90, creating a Sell signal.

Lumos Pharma (LUMO) Technical Indicators

Jul 22, 2024, 06:45 PM
Name
Value
Implied Action
RSI (14)
20.73
Buy
STOCH (9,6)
11.99
Buy
STOCHRSI (14)
9.90
Buy
MACD (12,26)
-0.25
Buy
ADX (14)
42.80
Neutral
Williams %R
-91.09
Buy
CCI (14)
-103.00
Buy
ATR (14)
0.19
-
Ultimate Oscillator
38.46
Neutral
ROC
-37.07
Sell
Lumos Pharma’s (LUMO) Relative Strength Index (RSI) is 20.73, creating a Buy signal.
Lumos Pharma’s (LUMO) Trend Strength Indicator (ADX) is 42.80, creating a Neutral signal.
Lumos Pharma’s (LUMO) Commodity Channel Index (CCI) is -103.00, creating a Buy signal.
Lumos Pharma’s (LUMO) Price Rate of Change (ROC) is -37.07, creating a Sell signal.

FAQ

Is LUMO a Buy, Hold, or Sell?
Based on LUMO’s technical indicators, LUMO is a Sell.
    What is LUMO’s RSI (14)?
    LUMO’s RSI (14) is 20.73, which suggests LUMO is a Buy.
      What is LUMO’s MACD?
      LUMO’s MACD is -0.25, which suggests LUMO is a Buy.
        What is LUMO’s 5-day moving average?
        LUMO’s 5-day moving average is 1.49, which suggests LUMO is a Sell.
          What is LUMO’s 20-day moving average?
          LUMO 20-day moving average is 1.96, which suggests LUMO is a Sell.
            What is LUMO’s 50-day moving average?
            LUMO’s 50-day moving average is 2.27, which suggests LUMO is a Sell.
              What is LUMO’s 200-day moving average?
              LUMO’s 200-day moving average is 2.90, which suggests LUMO is a Sell.
                What is LUMO’s Williams % R (14)?
                LUMO’s Williams % R (14) is -91.09, which suggests LUMO is a Buy.
                  What is LUMO’s CCI (14)?
                  LUMO’s CCI (14) is -103.00, which suggests LUMO is a Buy.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis